Why Most Reach-Through Royalty Claims Poison University-Industry Deals Before They Close
Reach-through royalty provisions look like smart IP protection but routinely kill university-industry deals. Here's what to do instead.
A. Kovacs Topic
IP strategy
7 posts tagged IP strategy from Commercializing Science.
A. Kovacs More on IP strategy
Why Most Confidentiality Agreements in Research Collaborations Backfire at the Worst Possible Moment
Most NDAs in university-industry research partnerships are written to protect everyone and end up protecting no one. Here's why, and what to do instead.
A. KovacsWhy Most Field-of-Use Restrictions in License Agreements Create More Problems Than They Solve
Field-of-use restrictions in university license agreements promise focused commercialization but routinely strangle deal value and block better applications from reaching market.
A. KovacsWhy Most IP Assignment Clauses in Research Agreements Sabotage the Deal Later
Vague IP assignment language in sponsored research agreements creates ownership disputes that kill commercialization deals years after the science is done.
A. KovacsWhy Exclusive Licenses Destroy More Value Than They Create
Exclusive licenses feel like wins for everyone at signing. Here's why they quietly kill commercialization, and what to structure instead.
A. KovacsWhy Most Invention Disclosure Forms Kill Commercialization Before It Starts
Invention disclosure forms are often the first step in tech transfer, and one of the most damaging. Here's what needs to change.
A. KovacsWhy Sponsored Research Agreements Are Where Commercialization Actually Begins
Sponsored research agreements shape IP ownership, licensing rights, and spinout potential before a patent is ever filed. Here's what most researchers miss.
A. Kovacs Browse more topics